Island Pharmaceuticals Engages Investors in Exciting Drug Trials
Company Announcements

Island Pharmaceuticals Engages Investors in Exciting Drug Trials

Island Pharmaceuticals Ltd (AU:ILA) has released an update.

Island Pharmaceuticals Ltd is actively engaging investors through a roadshow to update them on its promising antiviral drug developments, including the Phase 2a/b trial of ISLA-101 for dengue fever. The company is also exploring potential opportunities with its second asset, Galidesivir, signaling a dynamic phase with significant milestones ahead.

For further insights into AU:ILA stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App